Received 01/25/2022 review began 02/09/2022 review ended 05/23/2022 published 05/31/2022

HIGHLIGHTS

• who: Hypogonadal Symptoms and colleagues from the Medicine, Florida International University, Miami, USA Urology, University of Miami, Miami, USA have published the research: Received 01/25/2022 Review began 02/09/2022 Review ended 05/23/2022 Published 05/31/2022, in the Journal: (JOURNAL) of May/31,/2022
• what: Our results indicate that hCG monotherapy appears to safely improve hypogonadal symptoms, even with baseline T levels >300 ng/dL.
• future: Study is needed in a large randomized blinded fashion with validated questionnaires to determine the true efficacy of hCG monotherapy in the . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.